Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT07217639 · ClinicalTrials.gov registry record · NA
Clinical Validation of the Aptitude Medical Systems Metrix Respiratory Panel Test in At-Home/Non-Laboratory Settings
A NA study, sponsored by Aptitude Medical Systems.
- Not yet
- Registry status
- NA
- Development phase
- 2,000
- Enrollment target
NCT07217639 is a NA study that has not yet begun recruiting, run by Aptitude Medical Systems. The registered enrollment target is 2,000 participants.
The verdict
NCT07217639, a NA study, has not yet begun recruiting, sponsored by Aptitude Medical Systems.
- NOT YET RECRUITING
- Registry status
- NA
- Development phase
- 2,000 participants
- Enrollment target
Study Summary
The Metrix Respiratory Panel Test will be evaluated for use in Non-Laboratory settings in a home testing environment utilizing the clinical study design described herein. The study will take place in simulated home environments which will be set up within or near active clinical settings (e.g., urgent care facilities). This will be a prospective study conducted at three or more investigational sites located within the United States for the clinical validation of the Metrix Respiratory Panel Test for the detection of SARS-CoV-2, Influenza A, Influenza B, Respiratory syncytial virus, and Rhinovirus in anterior nares (AN) swab samples. Additional sites may be added to the study in order to meet minimum subject/sample enrollment requirements and geographic prevalence of respiratory virus infections. Comparator testing will be performed to determine the infection status of each sample for comparison to results generated by the candidate test. The primary comparator for the study will be an FDA-cleared assay for the detection of SARS-CoV-2, Influenza A, Influenza B, Respiratory Syncytial Virus, and Rhinovirus.
Interventions
- DIAGNOSTIC_TEST Aptitude Medical Systems Respiratory Panel Test
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 2,000 participants |
| Start Date | 2025-11-01 |
| Est. Completion | 2026-09-01 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT07217639
The ClinicalTrials.gov registry entry for NCT07217639 describes a study currently listed as not yet recruiting, categorized as NA. The registered enrollment target is 2,000 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Aptitude Medical Systems, which has 3 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 1 intervention - of which Aptitude Medical Systems Respiratory Panel Test is the first listed.
NCT07217639 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT07217639 about?
NCT07217639 is a clinical study titled "Clinical Validation of the Aptitude Medical Systems Metrix Respiratory Panel Test in At-Home/Non-Laboratory Settings". The Metrix Respiratory Panel Test will be evaluated for use in Non-Laboratory settings in a home testing environment utilizing the clinical study design described herein. The study will take place in simulated home environments which will be set up within or near active clinical settings (e.g., urge...
What is the current status of trial NCT07217639?
This trial is currently not yet recruiting. It is a NA study. The enrollment target is 2,000 participants. The study started on 2025-11-01. Estimated completion is 2026-09-01.
What interventions are being tested in trial NCT07217639?
The interventions under investigation include: Aptitude Medical Systems Respiratory Panel Test (DIAGNOSTIC_TEST).
Who is sponsoring clinical trial NCT07217639?
This trial is sponsored by Aptitude Medical Systems, which has 3 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.